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■ Abstract Background Differential diagnosis of schiz-
ophrenia and bipolar disorder is a challenging but im-
portant task. These conditions often exhibit overlapping
clinical symptomatology, but have different prognoses
and pharmacological management strategies. Factors
other than clinical presentation may influence diagno-
sis. Past studies suggest that ethnicity is one such factor,
with variations observed in diagnostic rates of serious
mental illness (SMI). With increasing attention paid to
provider cultural competency, we investigate current di-
agnostic practices within a veteran population. Method
Controlling for patient need characteristics and illness
severity, we examine whether ethnic differences in diag-
nosis continue to exist. If so,race may adversely enter the
evaluation process. A national database of all SMI veter-
ans explores the relationship between ethnicity and di-
agnosis. The role of symptomatology is also examined.
Given minimal variation in veteran socioeconomic sta-
tus, the Department of Veterans Affairs (VA) provides a
natural setting to address this confounding factor. The
1999 National Psychosis Registry provides a sample of
134,523 veterans diagnosed with schizophrenia,
schizoaffective disorder, or bipolar disorder. Multino-
mial logistic regression yielded odds ratios (OR) for be-
ing diagnosed with schizophrenia versus bipolar disor-
der; the schizoaffective versus bipolar risk was likewise
assessed,exploring theoretical aspects of a psychosis-af-
fective ‘continuum’. Results Small effects were observed
for being male, single or rural resident. However, the de-
mographic characteristic most strongly associated with
a schizophrenia diagnosis was race. The OR for African
Americans was 4.05, and 3.15 for Hispanics. Similar
though less dramatic results were revealed for schizoaf-
fective disorder. Conclusions This study confirms con-
tinued ethnic disparities in diagnostic patterns, and
highlights the importance of recognizing ethnic differ-
ences in symptom presentation while emphasizing
greater cultural competency.
■ Key words ethnicity – disparities – schizophrenia –
clinical diagnosis
Introduction
Differential diagnosis of schizophrenia and bipolar dis-
order is an important but difficult diagnostic task.
Cross-sectionally, these two serious mental illnesses
(SMI) can have similar clinical presentations; shared
symptomatology includes hallucinations, delusional be-
liefs, disorganized speech, and affective instability. How-
ever, unlike bipolar disorder, a diagnosis of schizophre-
nia requires a history of gradually declining functional
ability and delusional symptoms absent of a full mood
syndrome. An accurate diagnosis requires following a
patient over time and obtaining a complete history to
partition out the mix of psychotic symptoms and mood
disturbance. Clinicians might also assign patients the
diagnosis of schizoaffective disorder,a debatable middle
diagnostic ground [1]. Although the cross-sectional
symptoms may be similar, pharmacological manage-
ment and prognostic information for bipolar disorder
and schizophrenia are different. Second-generation
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atypical medications are prescribed to treat both disor-
ders, but their use for bipolar patients is often intermit-
tent and for shorter duration. Mood stabilizers, the front
line treatment course for bipolar disorder, are generally
ineffective for schizophrenia. Other treatment modali-
ties and clinical decisions also depend upon the partic-
ular SMI condition. Thus, an inappropriate diagnosis
may affect treatment decisions and suggest an inaccu-
rate prognosis.
Intertwined with the complexity of distinguishing
between these conditions is the question of diagnostic
stability. One hundred years ago, Kraepelin asserted that
schizophrenia and affective disorders were clearly dis-
tinct psychiatric conditions [2]. The debate remains
intriguing, with some investigators supporting a psy-
chosis – affective dichotomy [3, 4]. Yet, despite codifica-
tion inherent in the Diagnostic and Statistical Manual
for Mental Disorders (DSM), others argue for the exis-
tence of a continuum [5, 6] between these conditions. A
substantial portion of SMI patients receive a diagnosis
of both schizophrenia or bipolar disorder, even within a
short period. Race or ethnicity may be associated with
the stability of SMI diagnosis since distinct longitudinal
patterns have been observed across ethnic groups. For
example, Chen reported that African Americans change
more often from bipolar to schizophrenia diagnoses
over time than white patients, and less frequently in the
opposite direction [7].
Schizophrenia is generally considered to be the more
serious and debilitating disorder [8]. The social stigma
acquired through a schizophrenia label may contribute
to a lower quality of life [9, 10], and prove detrimental to
prognosis [11, 12]. Due to these concerns, the phenome-
non of diagnosing schizophrenia rather than bipolar
disorder has been labeled “misdiagnosis in a downward
direction” [13].
Unfortunately, factors other than clinical presenta-
tion and history may affect diagnosis. Past studies indi-
cate that race/ethnicity is one such factor. From the
1970s onward,differential diagnostic patterns have been
found consistently in both small observational studies
and in larger survey projects [14–21], with minorities
being diagnosed with schizophrenia at considerably
higher rates than white patients. Despite this composite
picture, these studies varied in sample size, definitions,
methods, and attempts to control for SES. As Neighbors
points out, while the literature supports an assertion of
ongoing diagnostic disparities, the evidence is “neither
clear nor definitive” [21].
Despite these repeated reports, little evidence exists
of true ethnic differences in the two disorders.When di-
agnoses are obtained using structured research inter-
views, both schizophrenia and bipolar disorder have
prevalence rates of approximately 0.8–1 % across all eth-
nic groups. Community studies, such as the Epidemio-
logical Catchment Area (ECA) study and National Co-
morbidity Survey (NCS), found no prevalence
differences by ethnicity for either condition after con-
trolling for socioeconomic status (SES) [22, 23].
SES is a significant consideration in any discussion
regarding psychiatric diagnosis. As early as 1854, Jarvis
documented a relationship between “insanity” and
lower social class [24]. Recent studies have confirmed
the contribution of disadvantageous SES towards schiz-
ophrenia: this disorder has been estimated at up to 8
more prevalent in lower versus higher SES groups
[25–27]. Significant associations have also been shown
between lower educational levels [23], lower occupa-
tional status [28], and urban residency [29]. SES level
has also been shown to be highly correlated with prog-
nosis and outcomes [30]. However, while SES is a poten-
tially important confounding factor, it seems to manifest
itself less variably within a veteran population.Most vet-
erans using VA services, especially SMI individuals, tend
to occupy the lower end of the SES spectrum [31]. SES
has been shown to contribute little towards care-seeking
behavior or outcomes among veterans using VA services
[32, 33].
Aside from SES, reasons for the differential diagnosis
are unclear. Numerous theories have been suggested.
Most frequently cited is a potential lack of provider cul-
tural sensitivity when interpreting patient symptoms
[34–38]. As Rogler notes,“the cultural distance between
the diagnostician and the client affects the degree of
psychopathology inferred and affects, too, the type of
disorder diagnosed” [39]. Specific examples include lin-
guistic differences or culturally specific vernacular be-
ing mistakenly identified as a thought disorder, a per-
ception of hostile attitudes and elevated dangerousness,
“excessive” somatic complaints, defensive body lan-
guage, or expressions of “healthy paranoia” by minority
patients being seen as pathological [20, 40]. Even the
content and amount of clinical information solicited
during a patient encounter has been shown to vary de-
pending on ethnicity [41]. Cultural gaps in the thera-
peutic process may translate into poor rapport between
client and provider, hampering open dialogue and in-
formation necessary for accurate diagnosis [42].
Another explanation for divergent diagnostic rates
can be found in the differences in expressed symptoma-
tology. Minorities have been reported to display more
first rank or positive symptoms on standardized assess-
ment instruments, such as increased frequency and
severity of hallucinations, anger, delusions, impulsivity,
paranoia or asocial feelings, and expressions of external
control. These symptoms may prompt a schizophrenia
diagnosis upon first contact with the patient [20, 43, 44].
Minority patients may also experience delays in receiv-
ing mental health treatment, either due to access prob-
lems or care-seeking behaviors, possibly exacerbating
their condition [45–49]. Roukema et al. speculate that
delays in seeking treatment factor directly into deterio-
rating bipolar symptoms, causing this disorder to be
mistaken for schizophrenia [50].
Finally, perhaps the most complex interaction is be-
tween SMI diagnosis and comorbid substance abuse.Per
the ECA, 47 % of patients with schizophrenia also have a
diagnosis of either alcohol or drug abuse. Concurrent
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substance abuse may alter psychiatric symptom presen-
tation and subsequent clinical diagnosis. Cannabis in
particular, but also alcohol and cocaine, can exacerbate
hallucinations, paranoia, mood swings, and violent be-
havior [51, 52]. Some investigators believe substance
abuse to be responsible for much of the misdiagnosis
problem, regardless of patient ethnicity [53, 54].
The NCS found that minorities have lower rates of
overall substance abuse than whites (OR for blacks is
0.35, and 0.80 for Hispanics), although there are diffe-
rences in alcohol versus drug use, with minorities being
less likely to use alcohol, but more likely to misuse other
drugs. However, as both Herd and Dawson note, sub-
stance abuse imparts greater deleterious effects upon
minorities, largely due to lower SES conditions and is-
sues with healthcare access [55, 56]. The differential
rates in substance use across ethnic groups narrows with
age [57].Potential disparities arise here as well, since mi-
norities presenting with dual diagnoses tend to be eval-
uated and treated for only one condition more often
than white patients [58].
The VA has successfully reduced ethnic disparities in
diagnosis and treatment across a spectrum of other
medical conditions [59]. However, the issue of diagnos-
tic patterns within a veteran SMI population has not
been thoroughly addressed. In this study, we benefit
from a large, comprehensive national sample from the
Department of Veterans Affairs Healthcare System to ex-
amine whether differential psychiatric diagnosis is still
present in the late 1990s. Increased sensitivity to the is-
sue of cultural competency, plus a recent Surgeon Gen-
eral’s report focusing on ethnicity and mental health
concerns [60], confirms the timely significance of this
research area.
The VA serves a unique mission and is devoted to a
special patient population. It is a highly integrated sys-
tem, in terms of clinical processes and data availability.
The largest healthcare organization in the United States,
the VA provided services to over 4 million veterans in
2002.The VA is often considered a rather “closed”health-
care system, treating individuals with relatively few
other options for care. The length of patient tenure
within the system, plus their satisfaction [61] and sense
of connection in regard to VA services is generally very
high. This combination of a captured and dedicated pa-
tient population, coupled with a notably low general SES
level, makes the VA a “natural laboratory” for examining
this issue. This study is by far the largest investigation of
ethnic disparities in the diagnosis of SMI patients. Fur-
thermore, the size and comprehensive nature of the data
available through the National Psychosis Registry allows
us to adjust for many potentially confounding factors.
The objective of this study examines whether ethnic
minority patients were diagnosed with schizophrenia
rather than bipolar disorder more frequently than
whites, controlling for SES and other patient character-
istics. We hypothesize that despite attention devoted to
minimizing ethnic disparities, plus the low SES variabil-
ity and lack of financial barriers to access, minority vet-
erans will nevertheless have a greater likelihood of re-
ceiving a schizophrenia diagnosis.
Methods and data analysis
■ Data source
Data on patient demographics, diagnoses, and healthcare utilization
were obtained from the National Psychosis Registry [62]. The Reg-
istry was developed by the Serious Mental Illness Treatment Research
and Evaluation Center (SMITREC) to monitor care provided to SMI
veterans. It is a comprehensive database and annual report covering
all veterans with a serious mental illness (SMI), and includes infor-
mation on demographics and other patient characteristics, inpatient
and outpatient utilization, pharmacy use, and costs. All patients re-
ceiving a diagnosis of a schizophrenia, schizoaffective disorder, or
bipolar disorder between October 1, 1998 and September 30, 1999
were included in the study population. Veterans were classified into
only one of the three major diagnoses; if patients received more than
one primary diagnosis during this period, an algorithm based upon
the most frequent category was used. This resulted in a total popula-
tion of 134,523 veterans with a qualifying diagnosis.
For a secondary analysis examining the role of symptom presen-
tation and severity, supplemental data were also used from another
veteran SMI population. The Long-Term Mental Health (LTMH) pro-
ject dataset is a subset of the Registry, with approximately 95 % of in-
dividuals interviewed for LTMH also included in the Registry. For this
subanalysis, Brief Psychiatric Rating Scale (BPRS) scores from the
LTMH questionnaires provided detailed information regarding clin-
ical symptomatology for 1,635 veterans with either schizophrenia or
bipolar disorder. Recognizing the importance of clinical presentation
during the diagnostic process, this secondary analysis reveals essen-
tial information regarding the association between symptom severity
and the diagnosis of psychiatric illness.
■ Measures
Ethnicity was categorized into three groups for analytical purposes:
White,African American or Hispanic.Much effort was devoted in cre-
ating the Registry to minimize missing race data, and valid informa-
tion was obtained for approximately 90 %. A variety of patient level
factors were incorporated into the analytic models to reflect demo-
graphic and illness severity characteristics pertinent to a diagnosis of
schizophrenia. Demographic variables included gender, marital sta-
tus, age, and mortality during the year. Urban residency reflected
whether or not a patient lived within a defined metropolitan statisti-
cal area. Utilization data within the past year served as a proxy indi-
cator for severity of illness, with specific measures being the number
of hospitalization days and outpatient mental health specialty visits.
Albeit not a perfect surrogate for illness severity, it is conceptually
valid, and a consistent association with utilization has been demon-
strated in both medical and mental health treatment [63–65]. A uti-
lization measure also captures the frequency of psychiatric specialty
contacts, and correlates with opportunities to receive an SMI diagno-
sis.
Two other relevant patient characteristics were also examined to
determine their relationship with SMI diagnosis. Reflecting the per-
centage of a patient’s disability attributable to his or her military com-
mitment, service connection functions as another proxy for illness
severity, in addition to representing a measure of access to and re-
liance upon VA care. A close association between this variable and
health services utilization has been demonstrated [66]. A “tenure”
variable has also been created to describe the number of years each
patient has been cared for by VA providers in the past decade, and de-
notes a measure of treatment longevity within the system.As with the
number of mental visits, we assumed that tenure level might be asso-
ciated with accuracy or consistency of diagnosis and, therefore,
wished to control for this factor.
Evaluating the role of comorbid substance abuse is complex as
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previously discussed. In lieu of longitudinal and other data pertain-
ing to the relationship between substance abuse and psychosis, a sim-
ple control variable was created. This dichotomous measure reflects
the existence of an additional outpatient diagnosis for either alcohol
or other substance use, dependence or abuse. For the purposes of this
study, two factors relating to substance abuse are pertinent: possible
differences in dual diagnosis rates by ethnicity,and whether or not in-
creased symptom severity is observed.
The National Psychosis Registry confirmed the low variability of
socioeconomic status among SMI veterans: 95 % of these individuals
reported annual incomes below $26,000. This variable was not in-
cluded in the primary model since approximately 60 % of patients did
not report income information.Yet, given the potential significance of
this factor, we endeavored to study its association with schizophrenia.
A further exploratory investigation was conducted in a sub-analysis
to gauge the impact of low SES.
■ Data Analysis
Controlling for potentially confounding variables as previously de-
scribed, a multinomial logistic regression model was used to estimate
the increased probability of being diagnosed with schizophrenia
(psychosis) versus bipolar disorder (affective) by race. This analysis
calculated the odds ratio (OR) of all factors contributing to a diagno-
sis of schizophrenia, including the likelihood of an ethnic minority
receiving that diagnosis in comparison with a white patient. This
model also provided a separate OR for schizoaffective versus bipolar
disorder, and explored the theoretical aspects of a ‘continuum’ in
schizophrenia-affective diagnoses. Finally, separate analyses using a
LTMH dataset were conducted to incorporate clinical symptomatol-
ogy and the role of actual illness presentation on psychiatric diagno-
sis. Statistical analyses were completed using SAS® System for Win-
dows, Release 8.02 by SAS Institute Inc., Cary, N. C.
Results
Of the entire population, 53.1 % (71,363) had an inclu-
sion diagnosis of schizophrenia; another 36.9 % (48,443)
were classified as bipolar, with the remaining 10.9 %
(14,717) receiving a schizoaffective diagnosis. The
ethnic composition was 69.5 % White, 23.6 % African
American, and 6.9 % Hispanic. Characteristic of an SMI
population, less than 30 % of these patients are married,
their average age was 52.6 years, and they are high uti-
lizers of care. The mean number of outpatient mental
health visits was 28.1 (s. d. = 54.1), with an average
number of inpatient days of 13.6 (s. d. = 36.0). The mean
income for this sample was only $11,845 annually
(s. d. = $8,344). Regarding the stability of diagnosis, it
should be also noted that over 25 % of all patients re-
ceived more than one category of the SMI diagnoses in
the same year. Table 1 presents the descriptive statistics
for this patient group, broken down by both diagnoses
and ethnicity. As a Registry subset, the LTMH profile is
very similar to the parent dataset in terms of patient
characteristics and utilization measures. For example,
the mean inpatient days and outpatient mental health
visits were 14.1 and 30.4 for LTMH patients compared to
13.6 and 28.1 for the Registry.
■ Bivariate results
Table 1 presents a comparison of the key model measures
by diagnosis and ethnic group.All of the bivariate associ-
ations between ethnicity or diagnosis and the other vari-
ables were statistically significant (p < 0.05). Regarding
ethnicity, greater differences are found between the two
minority groups themselves than between themselves
and White patients. African Americans and Hispanics
contrasted sharply with each other on rates of urban res-
idency,gender,dual diagnosis,marital status and utiliza-
tion. In terms of anticipated risk factors for schizophre-
nia,Hispanics actually displayed a slightly more favorable
profile than either of the other ethnic groups. Compared
with White patients,both minority groups had better ac-
cess in terms of service connection and demonstrated
longer “tenure” within the VA system. Several other vari-
ables characterized essential differences pertinent to this
study. Overall, patients with schizophrenia are much
more likely to be male, unmarried, utilize greater ser-
vices, report lower income, and have been treated within
the VA system longer. Comorbid substance abuse, how-
ever, was considerably higher in bipolar patients.
■ Multivariate results
Patients who were male, unmarried, or living in a rural
environment were more likely to be diagnosed with
schizophrenia rather than bipolar disorder. In addition,
higher mortality and service connection was also
strongly associated with a schizophrenia diagnosis, as
was longer tenure within the VA care system. Although
statistically significant, minimal or no effects were no-
ticed for age, and either of the utilization variables. Rec-
ognizing the predominantly male VA population, an in-
teraction model with gender*diagnosis was also run,
with no significant findings. Table 2 provides the ad-
justed odds ratios for each specific factor.
An appreciably different picture emerged when con-
sidering the question of ethnicity. After controlling for
possible confounders, race continued to most strongly
predict a schizophrenia diagnosis. The odds ratio for
African Americans was 4.05 (95 % C. I. 3.91–4.19), indi-
cating over four times greater likelihood of being diag-
nosed with schizophrenia instead of bipolar disorder rel-
ative to white patients. For Hispanics, the risk was also
highly elevated, with an OR of 3.15 (95 % C. I. 2.97–3.33).
Patients with comorbid substance abuse were more
likely to be diagnosed with bipolar disorder. Interaction
models exploring the link between ethnicity*dual diag-
nosis and schizophrenia did not provide additional in-
sights or alter the primary findings of this study. That is,
African American or Hispanic patients with a substance
abuse disorder were no more likely to be given a schizo-
phrenia diagnosis than those minorities without this co-
morbidity.
Turning to the second perspective examining
schizoaffective versus bipolar diagnoses, we found sim-
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ilar but less dramatic results. Minimal differences in ef-
fect sizes can be seen for patient characteristics and uti-
lization. Ethnicity, once again, is clearly the prevailing
factor: the OR for African Americans and Hispanics here
was 1.95 and 1.69, respectively. Although lower in com-
parison to a schizophrenia diagnosis, these remain
highly elevated and significantly increased probabilities
relative to White patients.
■ Secondary analyses
SES/income
A separate analysis was performed on those individuals
that possessed valid income data for FY99 (N = 49,901),
and the logistic regression re-run for a schizophrenia
versus bipolar diagnosis. After viewing the overall dis-
tribution, income was included as a categorical variable
(< $10K, $10–20K, $20–30K, $30+). The first notable
finding was a direct linear relationship with psychosis:
confirming expectations, as income dropped, the proba-
bility of a schizophrenia diagnosis increased (OR for
highest SES was 0.51 compared to lowest). Secondly, and
most significantly, when income was first added then
dropped from the model, the risk of a schizophrenia di-
agnosis in African Americans and Hispanics was only
attenuated 3 % and 4 %, respectively. While not mini-
mizing the conceptual importance of SES factors, these
results help support our hypothesis that it plays a rather
minor role within a SMI veteran population. Evidence of
differential diagnosis patterns across ethnic groups was
certainly not eliminated when including income in this
study.
All Schizophrenia SchizoAffective Bipolar
N 134,523 71,363 14,717 48,443
% 53.1% 10.9% 36.9%
Age (mean) 52.6 53.9 50.2 51.5
(SD) (12.7) (12.8) (11.3) (12.7)
Ethnicity
White 69.5% 59.9% 71.6% 83.1%
African American 23.6% 31.2% 22.4% 12.8%
Hispanic 6.9% 8.9% 6% 4.1%
Female, % 6.7% 4% 8.6% 10.1%
Married, % 29.9% 25.8% 27.9% 36.4%
Died in FY99, % 2.3% 2.8% 1.6% 1.6%
MSA resident, % 79.1% 78.2% 81.5% 79.6%
Dual dx, % 30% 25.6% 32.6% 35.7%
Service connection % 67.1 74.6 68.2 53.3
Institutional days 13.6 14.9 14.5 11.3
(SD) (36.0) (42.7) (39.5) (26.1)
Number of MH stops 28.1 28.8 32.2 25.8
(SD) (54.1) (64.0) (60.7) (48.2)
Tenure (past 10 years) 8.2 8.7 8.2 7.3
(SD) (2.9) (2.5) (2.8) (3.2)
Income $11,845 $10,358 $10,966 $13,294
(SD) ($8,344) ($7,343) ($7,821) ($11,887)
White African-American Hispanic
N 93,507 31,756 48,443
Age (mean) 53.7 49.3 53.5
(SD) (13.0) (11.1) (12.6)
Female, % 6.9% 7.1% 3.3%
Married, % 30.2% 22.7% 50.9%
Died in FY99, % 2.5% 1.8% 1.7%
MSA resident, % 77.8% 89.1% 57.4%
Dual dx, % 26.7% 41.1% 24.9%
Service connection % 65.9 68.0 74.2
Institutional days 14.0 14.1 7.5
(SD) (47.2) (41.6) (30.4)
Number of MH stops 27.3 32.5 20.9
(SD) (58.1) (62.3) (47.8)
Tenure (past 10 years) 8.0 8.5 8.6
(SD) (3.0) (2.6) (2.6)
Income $12,818 $8,915 $11,084
(SD) ($9,655) ($6,764) ($9,201)
Table 1 Descriptive results
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Presentation of symptoms (LTMH data)
Recognizing a multitude of possible confounding fac-
tors pertaining to care-seeking behavior, the use of non-
VA providers and services, plus provider and system
level factors that could not be addressed through an ad-
ministrative database,we examined the role of symptom
presentation in the clinical encounter. If indeed minor-
ity veterans presented with more severe symptoms, then
such differential symptomatology might explain our di-
agnostic findings. These differences could be attributed
to substance abuse, access problems or health beliefs de-
laying care until their psychiatric condition deterio-
rated.
Although the Psychosis Registry does not contain in-
formation regarding symptoms or severity of condition,
data on a similar population were observed in the sec-
ond large VA dataset. The LTMH project provides BPRS
scores of 1,635 veterans with schizophrenia and bipolar
disorder. For the purposes of this study, a bivariate com-
parison of positive and negative symptoms across eth-
nic groups was conducted. Only minor differences were
observed in the individual symptoms; in fact, when di-
chotomized into moderate or worse severity (score of 3+
on any item,0–6 scale),a level commonly viewed as a key
diagnostic predictor, none were significantly different
by ethnicity. Moreover, of the three symptoms where
minority veterans did have higher mean scores, two of
these (elation and grandiosity) are typically indicative
of a bipolar disorder more than schizophrenia.
No differences in symptomatology were found be-
tween patients with comorbid substance abuse com-
pared to those without a dual diagnosis, regardless of
ethnicity. Interestingly, for both the Registry and LTMH
populations, mean GAF scores were also slightly higher
in African Americans; this implies a higher functioning
patient group as perceived by providers, a description
contrary to the common perception of individuals with
schizophrenia. Per the Registry, the average GAF scores
for veterans with schizophrenia was 49.2 versus 54.1 for
bipolar patients. As a final analysis, equivalent logistic
models previously run on the Registry data were dupli-
cated in the LTMH sample; the elevated odds ratios plac-
ing minorities with a great probability for a schizophre-
nia diagnosis were only attenuated about 5 % when
presenting symptoms were incorporated. These results
provide some confirmatory evidence of diagnostic dis-
parities regardless of SMI symptoms or severity of ill-
ness (Figs. 1 and 2).
Discussion
To our knowledge, this is the first study to explore the
topic of potential misdiagnosis by race within a large na-
tional healthcare organization. Despite improvements
made in numerous other medical areas, these findings
confirm evidence of lingering disparities in psychiatric
diagnosis across ethnic groups. Consistent with previ-
ous research, a higher percentage of minority patients
received a diagnosis of schizophrenia. With the excep-
tion of a moderately protective effect for urban living,
the results confirmed and expanded upon previous
findings in the literature. Specifically, race appears to
matter and still appears to adversely pervade the clinical
encounter,whether consciously or otherwise.The highly
elevated likelihood of a minority veteran being classi-
fied as psychotic endured when controlling for a con-
stellation of relevant patient factors. Interestingly, de-
spite exhibiting a generally protective profile as
compared to White patients, the greater probability of
schizophrenia for Hispanic veterans appears especially
pronounced.
An elevated but attenuated likelihood for schizoaf-
SCH vs. BPa SCH vs. SchAffa
Variable Odds Ratio 95% CI Odds Ratio 95% CI
Age 1.01 1.01–1.01 0.99 0.99–0.99
Female 0.35 0.34–0.38 0.71 0.67–0.77
Married 0.47 0.46–0.49 0.66 0.63–0.69
OP mental health stops 1.00 1.00–1.00 1.00 1.00–1.00
Institutional days 1.00 1.00–1.00 1.00 1.00–1.00
Mortality (died in FY99) 1.71 1.56–1.87 1.10 0.95–1.28
MSA resident 0.85 0.83–0.88 1.02 0.97–1.07
Tenure in VA system 1.11 1.11–1.12 1.09 1.08–1.10
Substance abuse/dual dx 0.52 0.50–0.53 0.68 0.65–0.71
Service connection:
(reference is non-connected)
0–49 0.79 0.76–0.82 0.77 0.73–0.81
50–69 0.99 0.94–1.05 0.86 0.79–0.94
70+ 2.27 2.20–2.34 1.65 1.58–1.73
Race:
Black vs. White 4.05 3.91–4.19 1.95 1.86–2.05
Hispanic vs. White 3.15 2.98–3.33 1.69 1.56–1.84
a SCH schizophrenia; BP bipolar disorder; SchAff schizoaffective disorder
Table 2 Multivariate results
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fective disorder in comparison with schizophrenia can
be interpreted as lending some credence to the contin-
uum theory. That is, as a patient moves downwards to-
wards a more serious SMI condition, the probability of
an ethnic minority receiving that diagnosis increases ac-
cordingly.Also,as previously noted, a sizable proportion
of Psychosis Registry patients received more than one
primary diagnosis in FY99. Similar to the findings of
Chen, this also had an ethnic component, as minorities
were more likely to fluctuate between psychotic and af-
fective conditions. Restricting the analysis to individu-
als with only one diagnosis might shed additional in-
sight into the clinical encounter, as would a longitudinal
examination of the same patients over time.
The two conceivable areas of most significance for
potential confounding were socioeconomic status and
comorbid substance abuse. Both of these variables could
certainly affect symptom presentation or the manifesta-
tion of psychosis and, therefore, how a provider assessed
a patient. However, the fact that each of these variables
only marginally contributed to an elevated schizophre-
nia risk (i. e., 3–5 % each) makes it unlikely they are ad-
versely influencing our results.
Potentially more problematic is the question of co-
morbid substance abuse. In addition to the complex and
unexplored causal associations, plus detrimental effects
on care-seeking behavior, the presence of a dual diagno-
sis can exacerbate psychotic symptoms. If so, an assign-
ment of schizophrenia becomes quite reasonable and
differential diagnosis rates might be at least partially ex-
plained by different substance abuse prevalence across
ethnic groups. However, although African Americans
had a much higher rate of dual diagnosis than Whites,
Hispanic patients actually had a lower rate. Secondly, no
effects were observed in the relationship between sub-
stance abuse and symptom severity, nor with the inter-
action between schizophrenia, ethnicity and dual diag-
nosis status. This finding echoes the work of Munley
et al. who reported no differences in symptomatology
between African American and White veterans with
both schizophrenia and substance abuse [67].The seem-
ingly “protective” effect for being diagnosed with schiz-
ophrenia is misleading and simply in line with a sub-
stantial literature noting higher rates of comorbidity
among bipolar patients [68–70].
■ Limitations
Despite considerable attention to relevant confounding
factors, this is foremost a descriptive and retrospective
study using administrative data. Thus, although we are
able to document strong evidence regarding diagnostic
disparities, we cannot directly address specific reasons
for this issue. Notwithstanding an exploratory analysis,
the study could also not fully examine the role of symp-
tom presentation, nor incorporate provider clinical ex-
perience, judgment or interpretation of psychotic ele-
ments. Other dynamics might also affect these findings,
such as provider ethnicity and professional licensure
(e. g., psychiatrist, psychologist, MSW, mental health
specialist versus primary care, etc.), provider training
and cultural norms of practice, geographic region of the
country and/or ethnic composition of the area, and
whether or not the VA medical center has an academic
affiliation. Another unique feature of the VA, a predom-
inantly male population, should also be noted again.
While this might somewhat limit generalization to other
systems, we found no evidence suggesting in the litera-
ture or our analysis a differential effect between gender
and ethnicity.
We did not model the presence of post-traumatic
stress disorder (PTSD), which could also complicate the
diagnostic process due to overlapping symptomatology
with psychosis. However, the current literature is some-
what mixed regarding prevalence rates, epidemiology,
and differential impact of PTSD symptomatology [71,
72]. In some studies, Hispanics have higher PTSD rates
than other groups [73], though African Americans
might have more sub-clinical psychotic symptoms [74].
Yet other VA researchers have found no PTSD prevalence
or symptom differences by race [75, 76]. Furthermore,
Frueh (2002) did not find differences in the diagnosis of
psychosis in PTSD patients, despite these higher PTSD
symptoms levels.
Care-seeking behavior and access delays raise an-
other interesting and pertinent point, as we were unable
to specifically model to what extent these issues affect
Fig. 1 Risk of schizophrenia and schizoaffective diagnoses by ethnic group
Fig. 2 Risk of schizophrenia diagnosis. Main model from primary Psychosis Reg-




SMI diagnosis. Disparities have been noted in mental
health treatment and utilization rates. For example, mi-
norities have been shown to receive less specialty men-
tal health services [77], and fewer atypical antipsy-
chotics [78]. Given the mandate to provide care to all
veterans, problems with access by ethnicity vary little
within the VA. Harada has investigated the role of racial
identity and satisfaction on willingness to seek health-
care, and differences between ethnic groups [79, 80],
with no additional burden placed upon minorities.Since
veterans seeking care within the VA tend to be sicker
than those receiving treatment outside the system [81],
minimal bias from caring for only the healthiest indi-
viduals is also minimized here. Yet, if these factors con-
tribute to greater illness severity upon reaching a
provider, then a diagnosis of schizophrenia could be
more likely regardless of ethnicity.
Similarly, this study does not address how patients
seek care outside of the VA, nor to the extent that possi-
ble selection factor issues result. However, several stud-
ies have demonstrated that ethnic minorities might be
more comfortable and willing to seek mental healthcare
services [82, 83], and also tend to utilize such services
within the VA more than White veterans [84].Access dif-
ficulties have also been shown to be rather minimal,
with no differences by ethnicity; Washington and col-
leagues concluded that the VA’s ambulatory care system
is effective in mitigating ethnic disparities in this regard
[85]. In addition, Hoff and Rosenheck note that veterans
with either schizophrenia or high service connection
have minimal “out of system” use [86]. Given this back-
ground and the fact that illness severity was equivalent
across ethnic groups, we are confident that access issues
or selection bias are unlikely to account for our findings.
We recognize that income might be viewed as a poor
proxy for SES,and that the latter is not synonymous with
social class, occupational status or income alone. This
debate has led researchers to rely upon a combination of
measures to capture SES, with no clear consensus of the
most appropriate method. The complex association
with psychosis should certainly not be dismissed lightly
as SES has multiple dimensions. For example, we note
that occupation, but interestingly not education, has
been shown to play a role in the diagnosis and progno-
sis of schizophrenia [30]. Ideally, a finer multifaceted
form of SES could be incorporated analytically to study
this issue.However,given the overall lower SES status for
SMI veterans across many dimensions, we again believe
this is a relatively minor factor within the VA in terms of
diagnostic influence.
From a sociological perspective, there is also the
practical question of how “race” itself is classified and
used in administrative database. Prior and subsequent
to the 2000 census, the literature has focused attention
primarily upon the complicated and confounding na-
ture of using ethnicity in health services research
[87–89]. Although by no means a trivial issue, this com-
plex subject falls outside the scope of our analysis. Ac-
curacy or extensive missing race data in VA administra-
tive records can be a potential problem as well. Fortu-
nately, a recent article supports internal VA discussion
and analysis confirming the accuracy of veteran ethnic-
ity data, and the appropriateness of relying on that in-
formation in this study [90].
Despite these possible limitations, we return once
more to actual symptom presentation. The fact that
overt illness severity did not appear to vary by race irre-
spective of the influence of SES, comorbid substance
abuse, and possible care-seeking differences lends some
credence to the term “diagnostic disparity”. In a smaller
observational study, Hutchinson also determined that
minor differences in symptomatology cannot account
for variations in schizophrenia diagnosis [91]. Further-
more, in separate research efforts, Weisman and Brekke
found that ethnic minorities displayed significantly
fewer psychotic symptoms than White patients [92, 93].
Clearly, the relevance of psychotic symptoms to clinical
diagnosis highlights these findings and suggests that ad-
ditional work in this area is required.
Notwithstanding numerous challenges to psychiatric
classification itself, from Thomas Szasz to more recent
critics [94], many forces shape the clinical encounter
and subsequent diagnosis. The powerful influence of so-
cial construction in mental health [95] has also been
noted, in addition to the questionable usefulness of a
schizophrenia label itself [96]. The combination of pa-
tient, provider and system factors, plus other unrecog-
nized dimensions, conspires to produce an extremely
difficult and daunting assessment task for the clinician.
Choosing one diagnosis over another is indeed a com-
plex process. As Westermeyer nicely summarizes,“diag-
nosis involves more than a mere Linnaean classification
of homogeneous entities” [97]. Researchers and clini-
cians alike can appreciate why diagnostic stability and
accuracy debates have lingered for such a long time.
Several interesting policy implications arise from
these findings. Foremost is the role of DSM criteria in
clinical practice and some have questioned how fre-
quently it is truly consulted in clinical practice [98].Jones
and others have commented that the DSM-III was specif-
ically intended to introduce greater standardization in
SMI diagnoses, while reducing the ethnic component
[40].Yet,conversely,the DSM-IV is commonly believed to
represent a tremendous advancement by more specifi-
cally incorporating culture into the clinical process [99].
In addition to doubting the success of either revision,the
importance of cultural factors raises the debate over the
very appropriateness of this mission, that is, should cul-
ture be overtly excluded from diagnostic assessment? In
either case, the use of culturally sensitive structured in-
struments (e. g., CIDI) has also been advocated to mini-
mize diagnostic variability [100].
As mentioned, organizations should also recognize
the contribution of provider and system factors, and not
only patient dynamics. In that light, ethnic matching of
patient and provider is occasionally forwarded as a pos-
sible remedy. However, previous research has shown
negligible results in terms of mental health outcomes, or
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reducing the imbalance of SMI diagnosis by ethnicity
[101–103].Above all, regardless of other considerations,
the overwhelming body of literature and results clearly
encourages the promotion of greater cultural compe-
tency and awareness in working with minority patients.
We also note that calls for improvement in this area are
not equivalent to charges of “racial bias”, nor do these
results regarding diagnostic differences in any way im-
ply such criticism.
In line with the results of this study and the policy
implications, there exists a rich avenue for future re-
search directions. Further research might focus upon
first-contact appointments and diagnosis (e. g., hospital
admission, or initial outpatient visit), limiting the sam-
ple to patients with only one primary diagnosis, and a
longitudinal analysis to gauge stability over time. With
available data, the influence of provider and system fac-
tors would also be illuminating, as would an exploration
of regional differences: the Psychosis Registry has re-
vealed substantial differences in diagnostic patterns
across the VA’s 22 national networks or VISNs. Finally,
the link between clinical assessment, actual treatment,
and outcomes will document the actual role of diagno-
sis, i. e., how treatment might differ across ethnic groups
depending on the assigned SMI diagnosis.
As Zuvekas et al. note in their recent decomposition
of contributing factors, a sizable portion of ethnic dis-
parities in any medical realm simply cannot be ex-
plained via observable data, no matter how comprehen-
sive [104]. Numerous conceptual themes and practical
concerns are involved: cultural context and sensitivity,
fine shades of diagnostic meaning, confounding comor-
bidities, patient-provider rapport, SES factors, role of
strict DSM application, health beliefs, care-seeking be-
havior, access issues, and so on. Nevertheless, in control-
ling for pertinent patient side factors, our findings not
only demonstrate a profound pattern of diagnostic dis-
parities,but also represent a significant step in better de-
lineating the intricate black box of possible causes.
Conclusion
This study utilized a comprehensive national database
to delve into the complex waters of psychiatric diagno-
sis. Despite the acknowledged limitations of presenting
descriptive inferences in psychiatric diagnosis through
administrative data, these results highlight an ongoing
concern in the evaluation and treatment of SMI vete-
rans. Recognizing the multi-faceted nuances that com-
prise the mental health encounter, patient factors alone
cannot explain the widely divergent diagnostic patterns
seen here. The acutely elevated risk of a schizophrenia
designation in minority patients warrants serious atten-
tion, especially considering the significant ramifications
for appropriate treatment and outcomes. Accurate as-
sessment of these vulnerable veterans requires a height-
ened sensitivity and awareness to cultural competency
as the VA continues striving to eliminate ethnic dispari-
ties in all spheres of clinical practice. In addition to a
more refined examination of symptom presentation and
comorbid substance abuse issues, further research
should focus upon relevant provider and system factors
that contribute to psychiatric diagnosis.
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